| Trading Companies & Distributors Industry | Industrials Sector | Yi-Kuan Lin CEO | OTC PINK Exchange | 72703D100 CUSIP |
| TW Country | 180 Employees | - Last Dividend | 19 Sep 2008 Last Split | - IPO Date |
Plandaí Biotechnology, Inc. is a company that specializes in producing proprietary botanical extracts, primarily for use in the nutraceutical and pharmaceutical industries. With a focus on harnessing the power of botanicals, Plandaí is dedicated to developing high-quality extracts that offer various health benefits. The company operates from its base in London, United Kingdom, but its activities span across the globe, notably on the Senteeko Tea Estate in Mpumalanga, South Africa. This location is pivotal for their research and production activities, particularly for the development of their flagship products such as the Phytofare Catechin Complex. Additionally, Plandaí Biotechnology engages in the production and sale of timber and agricultural products, leveraging the abundant resources from its farm and tea estate holdings in South Africa.
This botanical extract, derived from green tea harvested in the Senteeko Tea Estate, represents Plandaí Biotechnology's forefront product. The complex aims to offer a more bioavailable form of catechins, naturally occurring antioxidants found in green tea, promising enhanced health benefits over standard green tea extracts.
Similar to the Phytofare Catechin Complex, this product focuses on extracting bioavailable compounds from citrus fruits. These extracts are developed for various health applications, including immunity boosting and antioxidant properties, to serve the nutraceutical and pharmaceutical sectors.
Plandaí is also working on developing extracts from tomato fruit, which are rich in lycopene and other vital nutrients. These extracts are intended for use in both nutraceutical products and functional foods, capitalizing on the antioxidant properties of tomatoes.
The company explores the potential of Artemisia, a genus of plants with known medicinal properties. These extracts are being developed for their possible use in treating various ailments, contributing to the pharmaceutical segment with natural alternatives.
Recognizing the burgeoning demand for cannabis-related products, Plandaí is involved in the research and development of cannabis extracts. These are being pursued for their potential benefits in pain management, neurological disorders, and as natural therapeutic compounds.
Beyond extracts, Plandaí produces and sells timber and a variety of agricultural products sourced from its farm and tea estate holdings in South Africa. This diversification allows the company to utilize its landholdings effectively, contributing to its revenue stream beyond the core focus on botanical extracts.